Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

By Suzanne Hodsden

Iowa State scientists have developed a working battery that dissolves and disperses in water. Scientific illustration by Ashley Christopherson, courtesy of Iowa State University.

Scientists at Iowa State University (ISU) have introduced what they claim is the first practical transient battery that could be adapted for use in implanted medical devices. Their technology demonstrates the same shelf life and powering capabilities of commercially available batteries, and can dissolve in water in less than thirty minutes.

Next-generation medical implants are getting smaller, doing away with wires and, in some cases, are designed to dissolve when their practical use has expired.

Albany, NY -- (SBWIRE) -- 08/10/2016 -- The global market for small bone and joint orthopedic devices is largely consolidated, limiting the competition between Depuy Synthes, Wright Medical Group, and Zimmer Biomet Holdings Inc., the top three manufacturers of small bone and joint orthopedic devices across the world, finds Transparency Market Research (TMR) in a recent report. According to TMR, in 2014, these players collectively occupied a share of more than 70% in the overall market. Their wide-ranging product portfolios have helped them immensely in gaining a strong foothold in this market.

Going forward, TMR recommends these manufacturers to focus on increasing research and development activities to introduce innovative and highly advanced products at minimal costs in order to gain a competitive edge.

Tampa, Florida – Umbra Applied Technologies Group Inc. announced that its next generation bone fixator, ClearView G2 is ready for release with initial pilot surgeries to be completed over the course of the next 90 days.

Five years ago, through a strategic partnership with GE, Umbra Applied Technologies created the ClearView wrist fixator. The ClearView fixator was the world's first medical grade Lexan based wrist fixator that produced clearer X-ray views of fractured bone reduction and pin placement. The paradigm shifting device further raised the bar by being radiolucent thus reducing the amount of necessary times a clinical staff and patient needed to be exposed to radiation.

Here are four key notes:

1. The technology was designed as part of an ongoing collaboration with the Network's researchers.

2. This is the second product OrthoPediatrics has developed with the Network.

3. The technology offers a smaller and lower profile physeal tethering option, according to OrthoPediatrics' Executive Vice President David Bailey.

4. The technology is intended for foot and ankle as well as elbow and wrist procedures.

More articles on devices:
Flower Orthopedics launches the MTP Fusion Plate Portfolio: 3 things to know

Here are five insights:

1. The updated guidance resembles the original 1997 FDA guidance, but clarifies certain submission aspects.

2. The guidance suggests manufacturers perform a risk-based assessment to see if a modification would impact the device's safety or effectiveness.

3. The updated guidance offers flow charts that pinpoint when manufacturers need to submit a new 510(k) for labeling, materials, technology, engineering and performance changes.

4. Manufacturers can also turn to the guidance to determine which device changes mandate a new 510(k) and which don't.